Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessment of Motor Unit Potentials Duration as the Biomarker of DT-DEC01 Cell Therapy Efficacy in Duchenne Muscular Dystrophy Patients up to 12 Months After Systemic-Intraosseous Administration.
Niezgoda A, Biegański G, Wachowiak J, Czarnota J, Siemionow K, Heydemann A, Ziemiecka A, Sikorska MH, Bożyk K, Siemionow M. Niezgoda A, et al. Arch Immunol Ther Exp (Warsz). 2023 Nov 24;71(1):24. doi: 10.1007/s00005-023-00691-y. Arch Immunol Ther Exp (Warsz). 2023. PMID: 37999748 Free PMC article.
Safety and Efficacy of DT-DEC01 Therapy in Duchenne Muscular Dystrophy Patients: A 12 - Month Follow-Up Study After Systemic Intraosseous Administration.
Siemionow M, Biegański G, Niezgoda A, Wachowiak J, Czarnota J, Siemionow K, Ziemiecka A, Sikorska MH, Bożyk K, Heydemann A. Siemionow M, et al. Among authors: niezgoda a. Stem Cell Rev Rep. 2023 Nov;19(8):2724-2740. doi: 10.1007/s12015-023-10620-3. Epub 2023 Sep 14. Stem Cell Rev Rep. 2023. PMID: 37707670 Free PMC article.
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up.
Heydemann A, Bieganski G, Wachowiak J, Czarnota J, Niezgoda A, Siemionow K, Ziemiecka A, Sikorska MH, Bozyk K, Tullius SG, Siemionow M. Heydemann A, et al. Among authors: niezgoda a. Stem Cell Rev Rep. 2023 Jul;19(5):1340-1359. doi: 10.1007/s12015-023-10530-4. Epub 2023 Mar 31. Stem Cell Rev Rep. 2023. PMID: 37000376 Free PMC article.
The Limitations of Cytomegalovirus DNA Detection in Cerebrospinal Fluid of Newborn Infants With Congenital CMV Infection: A Tertiary Care Neonatal Center Experience.
Czech-Kowalska J, Jedlińska-Pijanowska D, Kasztelewicz B, Kłodzińska M, Pietrzyk A, Sarkaria E, Dunin-Wąsowicz D, Gradowska K, Niezgoda A, Gruszfeld D, Dobrzańska A. Czech-Kowalska J, et al. Among authors: niezgoda a. Pediatr Infect Dis J. 2021 Sep 1;40(9):838-845. doi: 10.1097/INF.0000000000003205. Pediatr Infect Dis J. 2021. PMID: 34285168
42 results